Skip to main content
Top
Published in: Journal of Endocrinological Investigation 5/2017

01-05-2017 | Comment

HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series

Authors: S. Cantara, C. Marzocchi, M. G. Castagna, F. Pacini

Published in: Journal of Endocrinological Investigation | Issue 5/2017

Login to get access

Abstract

Introduction

Thyroid cancer may have a familial predisposition and may occur in the context of hereditary syndromes or as isolated tumor. Recently, the G534E variant in the HABP2 gene has been suggested as causative mutation for familial thyroid cancer, but other studies gave contradictory results.

Methods

We have analyzed the G534E variant in an Italian series of 63 familial thyroid cancer patients and 41 unaffected family members with end-point PCR, DHPLC and direct sequencing.

Results

All samples analyzed displayed a pattern typical of the homozygous wild type revealing the absence of the G534E variant.

Conclusion

In this study, HABP2 G534E variant is not correlated with the familial form of PTC.
Literature
1.
go back to reference Marcucci G, Cianferotti L, Beck-Peccoz P, Capezzone M, Cetani F, Colao A, Davì MV, degli Uberti E, Del Prato S, Elisei R, Faggiano A, Ferone D, Foresta C, Fugazzola L, Ghigo E, Giacchetti G, Giorgino F, Lenzi A, Malandrino P, Mannelli M, Marcocci C, Masi L, Pacini F, Opocher G, Radicioni A, Tonacchera M, Vigneri R, Zatelli MC, Brandi ML (2015) Rare diseases in clinical endocrinology: a taxonomic classification system. J Endocrinol Invest 38:193–259. doi:10.1007/s40618-014-0202-6 CrossRefPubMed Marcucci G, Cianferotti L, Beck-Peccoz P, Capezzone M, Cetani F, Colao A, Davì MV, degli Uberti E, Del Prato S, Elisei R, Faggiano A, Ferone D, Foresta C, Fugazzola L, Ghigo E, Giacchetti G, Giorgino F, Lenzi A, Malandrino P, Mannelli M, Marcocci C, Masi L, Pacini F, Opocher G, Radicioni A, Tonacchera M, Vigneri R, Zatelli MC, Brandi ML (2015) Rare diseases in clinical endocrinology: a taxonomic classification system. J Endocrinol Invest 38:193–259. doi:10.​1007/​s40618-014-0202-6 CrossRefPubMed
3.
go back to reference Alzahrani AS, Murugan AK, Qasem E, Al-Hindi H (2016) HABP2 gene mutations do not cause familial or sporadic non-medullary thyroid cancer in a highly inbred middle eastern population. Thyroid 26:667–671. doi:10.1089/thy.2015.0537 CrossRefPubMed Alzahrani AS, Murugan AK, Qasem E, Al-Hindi H (2016) HABP2 gene mutations do not cause familial or sporadic non-medullary thyroid cancer in a highly inbred middle eastern population. Thyroid 26:667–671. doi:10.​1089/​thy.​2015.​0537 CrossRefPubMed
5.
go back to reference Colombo C, Muzza M, Perrino M, Cirello V, Proverbio M, Fugazzola L (2016) HABP2 gene mutations do not cause familial papillary thyroid cancer in a large series of unrelated families. Eur Thyroid J 5(Suppl. 1):69 Colombo C, Muzza M, Perrino M, Cirello V, Proverbio M, Fugazzola L (2016) HABP2 gene mutations do not cause familial papillary thyroid cancer in a large series of unrelated families. Eur Thyroid J 5(Suppl. 1):69
6.
go back to reference Cantara S, Pisu M, Frau DV, Caria P, Dettori T, Capezzone M, Capuano S, Vanni R, Pacini F (2012) Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer. J Clin Endocrinol Metab 97:E1327–E1331. doi:10.1210/jc.2011-2096 CrossRefPubMed Cantara S, Pisu M, Frau DV, Caria P, Dettori T, Capezzone M, Capuano S, Vanni R, Pacini F (2012) Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer. J Clin Endocrinol Metab 97:E1327–E1331. doi:10.​1210/​jc.​2011-2096 CrossRefPubMed
8.
go back to reference Ciampi R, Romei C, Pieruzzi L, Tacito A, Molinaro E, Agate L, Bottici V, Casella F, Ugolini C, Materazzi G, Basolo F, Elisei R (2016) Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland. J Endocrinol Invest. doi:10.1007/s40618-016-0526-5 PubMed Ciampi R, Romei C, Pieruzzi L, Tacito A, Molinaro E, Agate L, Bottici V, Casella F, Ugolini C, Materazzi G, Basolo F, Elisei R (2016) Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland. J Endocrinol Invest. doi:10.​1007/​s40618-016-0526-5 PubMed
Metadata
Title
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series
Authors
S. Cantara
C. Marzocchi
M. G. Castagna
F. Pacini
Publication date
01-05-2017
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 5/2017
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-016-0583-9

Other articles of this Issue 5/2017

Journal of Endocrinological Investigation 5/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.